申请人:Naya Akira
公开号:US20090137587A1
公开(公告)日:2009-05-28
A compound represented by the formula (I) is contained as an active ingredient:
wherein R
1
and R
2
independently represent a hydrogen atom, a lower alkyl group or the like, or R
1
together with a nitrogen atom to which L, Z
2
and R
1
are attached may form an aliphatic nitrogenated heterocyclic group and R
1
and R
2
together with a nitrogen atom to which they are attached may form an aliphatic nitrogenated heterocyclic group; X represents a methine group or a nitrogen atom; Y represents —CH
2
—O—, —CH═CH— or the like; Z
1
represents a single bond, a C
1-4
alkylene group or the like; Z
2
represents a single bond or a C
1-4
alkylene group; L represents a methylene group, a C
3-8
cycloalkylene group or the like; and Ar represents an aromatic carbocyclic group or the like. The compound is useful as a pharmaceutical for a central nerves system disease, a cardiovascular disease or a metabolic disease.
化合物的化学式为(I),其中包含作为活性成分的化合物:其中R1和R2独立地表示氢原子,低碳基团或类似物,或者R1与L,Z2和R1附着的氮原子一起可以形成脂肪族氮杂环基团,R1和R2与它们附着的氮原子一起可以形成脂肪族氮杂环基团;X表示亚甲基基团或氮原子;Y表示-CH2-O-,-CH═CH-或类似物;Z1表示单键,C1-4烷基撇或类似物;Z2表示单键或C1-4烷基撇;L表示亚甲基基团,C3-8环烷基撇或类似物;Ar表示芳香族碳环基团或类似物。该化合物可用作中枢神经系统疾病、心血管疾病或代谢性疾病的药物。